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The WH1 and EVH1 Domains of WASP and Ena/VASP
Family Members Bind Distinct Sequence Motifs
To examine if the WH1 domain does indeed interact
with proline-rich ligands, we sought to characterize the
N-WASP binding motif in the WASP binding domain of
Markus Zettl and Michael Way1
Cell Motility Laboratory
Cancer Research UK
Lincoln’s Inn Fields Laboratories WIP (residues 413–503). Peptides corresponding to the
four proline-rich sequences in the WIP-WBD were tested44 Lincoln’s Inn Fields
London, WC2A 3PX for their capacity to retain the N-WASP WH1 domain
from an Escherichia coli soluble fraction (Figures 1AUnited Kingdom
and 1B). Surprisingly, all four peptides failed to show
significant binding, suggesting either that the interaction
site is elsewhere or that efficient WH1 binding requiresSummary
a larger sequence motif than is required for the EVH1
domain. Consistent with these suggestions, recent stud-A complex of N-WASP and WASP-interacting protein
ies with the mammalian WIP homologs CR16 and WICH(WIP) plays an important role in actin-based motility
have demonstrated that exon 7 of CR16 and the equiva-of vaccinia virus and the formation of filopodia [1, 2].
lent region in WICH, which are 50% and 47% identicalWIP is also required to maintain the integrity of the
to residues 448–481 of human WIP, respectively, interactactin cytoskeleton in T and B lymphocytes and is es-
with N-WASP [13, 14]. We therefore performed identicalsential for T cell activation [3, 4]. However, in contrast
pull-down assays with a larger peptide correspondingto many other N-WASP binding proteins, WIP does not
to residues 451–473 of WIP. This larger peptide wasstimulate the ability of N-WASP to activate the Arp2/3
found to be extremely efficient at binding the N-WASPcomplex [2]. Although the WASP homology 1 (WH1)
WH1 domain (Figure 1B). As expected from our previousdomain of N-WASP interacts directly with WIP [2, 5,
observations [1], the WH1-W54A mutant protein failed6], we still lack the exact nature of its binding site. We
to bind residues 451–473 of WIP (data not shown). Thehave now identified and characterized the N-WASP
strong binding of WH1 to residues 451–473 of WIP andWH1 binding motif in WIP in vitro and in vivo using
the lack of significant binding to the shorter peptideShigella and vaccinia systems. The WH1 domain, which
(ISDLPPPEPYVQ) prompted us to wonder whether theis predicted to have a similar structural fold to the
WH1 binding site was in fact in the N-terminal half ratherEna/VASP homology 1 (EVH1) domain [7, 8], binds to
than the proline-rich C-terminal half of peptide E (Figurea sequence motif in WIP (ESRFYFHPISD) that is very
1A). We therefore performed pull-down assays with adifferent from the EVH1 proline-rich DL/FPPPP ligand
peptide corresponding to residues 451–461 of WIP (ES[9–11]. Interaction of the WH1 domain of N-WASP with
RFYFHPISD). We found that residues 451–461 of WIPWIP is dependent on the two highly conserved phenyl-
(peptide F) are sufficient to efficiently bind the WH1alanine residues in the motif. The WH1 binding motif
domain of N-WASP (Figure 1C).we have identified is conserved in WIP, CR16, WICH,
Identification of the EVH1 binding motif (DL/FPPPP)and yeast verprolin.
was facilitated by characterization of the interaction be-
tween VASP and the proline-rich repeats of ActA, the
Results and Discussion bacterial surface protein responsible for initiating the
actin-based motility of Listeria [9–11]. VASP binding
Biochemical studies and extensive analysis with the studies have also been performed on known SH3 and
yeast two hybrid system have demonstrated that WIP WW/WP proline-rich ligands [9]. These data, however,
binds to the WH1 domain of N-WASP and WASP [1, 2, do not rule out the possibility that the EVH1 domain
5, 6]. The residues in WIP with which the WH1 domain of Ena/VASP family members might also bind residues
interacts are, however, unknown. The strong sequence 451–461 of WIP, albeit with reduced affinity. To test
conservation between the WH1 and the EVH1 domains, whether residues 451–461 of WIP are specific for the
including the residues involved in coordinating EVH1 WH1 domain, we examined the binding properties of
binding to FPPPP ligands, suggests that the WH1 do- the EVH1 domain from VASP. We found that, although
main may also bind a proline-rich ligand [7, 8, 11, 12]. the VASP EVH1 domain was able to bind a control
Consistent with this notion, the WASP binding domain FPPPP peptide found in ActA, it was unable to bind
(WBD) in WIP consists of 26% proline residues and con- the peptide corresponding to residues 451–461 of WIP
tains four proline sequence motifs, one of which (Figure 1D). Our data show that, although the WH1 and
(DLPPPEP) is closely related to the VASP EVH1 binding EVH1 domains are predicted to have a similar structural
motif [5] (Figure 1A). Furthermore, mutation of trypto- fold and are thus often grouped together, for example
phan 54 in the N-WASP WH1 domain to alanine abol- [9–11], they do in fact have distinct binding motifs.
ishes its ability to interact with WIP [1]; an equivalent The alignment of the N-WASP WH1 binding motif,
residue to that found in this domain is essential in coordi- which we have identified in WIP, with the corresponding
nating the interaction with proline-rich sequences in the regions of CR16 and WICH reveals that it is a highly
EVH1 domains of Evl and Mena [7, 8]. conserved amino acid sequence (Figure 2A). Pull-down
assays with the equivalent sequence motifs of CR16
and WICH confirmed that they are also capable of bind-1Correspondence: michael.way@cancer.org.uk
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Figure 1. Identification of the WH1 Binding Site in WIP In Vitro
(A) A schematic representation of WIP showing the relative position of the WASP binding domain (WBD) and the peptides (A–F) used for in
vitro binding studies. The amino acid sequence of these peptides and their N-WASP WH1 binding activity are indicated.
(B) A Coomassie-stained gel showing that the His-tagged WH1 domain of N-WASP is retained from a soluble E. coli extract (sol) by nickel
resin (Ni) and peptide E, but not by peptides A–D.
(C) A Coomassie-stained gel showing that residues 451–461 of WIP (peptide F) are sufficient to interact with the WH1 domain of N-WASP.
(D) A Coomassie-stained gel showing that the His-tagged EVH1 domain of VASP, from a soluble E. coli extract (sol), binds to the nickel resin
(Ni) and the positive control ActA peptide FPPPP, but not to the negative control ActA peptide APPPP or residues 451–461 of WIP (peptide F).
ing the WH1 domain of N-WASP (Figure 2B). It was few proteins, except for WIP family members, via this
binding site.noticeable, however, that the CR16 peptide consistently
retained less WH1 than the other two peptides, sug- To identify which residues are required for the interac-
tion of WIP with the WH1 domain of N-WASP, we ana-gesting that it has a lower affinity for N-WASP than either
WIP or WICH. The WH1 binding motif is also conserved lyzed the effects of alanine substitution on the most
conserved residues in the motif. We found that onlyin the more divergent verprolin (End5), the WIP homolog
in yeast that interacts with Las17 (Bee1), the yeast ho- changes of the two central phenylalanine residues to
alanine had any noticeable affect on WH1 binding (Fig-molog of WASP [15–17]. Interestingly, extensive homol-
ogy searches using the conserved WIP motif failed to ure 2C). Substitution of phenylalanine 454 resulted in
reduced binding, while changing phenylalanine 456 toidentify any potential novel WH1 binding proteins, al-
though they readily identify homologs of WIP, CR16, alanine almost completely abolished the interaction with
the WH1 domain. When both phenylalanine 454 and 456and WICH in other species. This suggests that the WH1
domain of N-WASP and WASP interacts with relatively were substituted for alanine, all binding was eliminated
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Figure 2. Phenylalanine 454 and 456 of WIP Are Involved in WH1 Binding In Vitro
(A) The alignment of the WIP homologs CR16 and WICH, which bind N-WASP, reveals that the WH1 binding motif in WIP is highly conserved.
The motif is also readily observed in verprolin, the yeast homolog of WIP. The consensus shows positions at which four out of the five aligned
proteins have identical residues or a conserved charge.
(B) A Coomassie-stained gel showing that the motif found in WIP, WICH, and CR16 (indicated in [A]) binds the N-WASP WH1 domain, but
not the mutant WH1-W54A.
(C) A Coomassie-stained gel showing the effects of alanine substitutions on the ability of residues 451–461 of WIP (peptide F) to retain the
WH1 domain from identical amounts of soluble E. coli extract (sol). Substitution of phenylalanine 454 and 456 for alanine leads to a reduced
binding, while mutation of both residues completely abolishes the interaction.
(Figure 2C). Our in vitro binding assays demonstrate measure of the effect of our mutations on their affinity
for N-WASP in vivo. Our previous studies have, however,that, although the N-WASP WH1 binding motif contains
a number of conserved residues, the principal residues shown that, in contrast to the situation with Shigella,
the expression of WIP-WBD inhibits N-WASP recruit-involved in binding are the central phenylalanines.
To confirm whether our in vitro biochemical observa- ment and subsequent actin-based motility of vaccinia
[1]. Therefore, by examining the ability of the differenttions reflect the in vivo requirements for WIP binding to
N-WASP, we took advantage of the Shigella and vac- phenylalanine-to-alanine mutations in WIP-WBD to in-
hibit vaccinia-induced actin tail formation, it is possiblecinia pathogen systems. Our previous observations
have shown that, when expressed in infected cells, the to obtain quantitative data that can be compared with
our in vitro studies. Expression of wild-type GFP-WIP-WIP-WBD is recruited to Shigella nucleating actin tails
[1]. We therefore examined the ability of GFP-tagged WBD blocked viral recruitment of N-WASP and inhibited
vaccinia-induced actin tail formation by 71.8%  4.8%WIP-WBD, which contains the phenylalanine 454 and
456 to alanine substitutions, to be recruited to Shigella. (Figures 3B and 3C). In contrast, GFP alone did not block
N-WASP recruitment and gave a 8.5% 1.7% reductionWe found that GFP-WBDF454A was largely cytoplasmic
but was capable of being recruited to Shigella nucleating in actin tail formation when compared to untransfected
controls on the same coverslip (data not shown andactin tails on rare occasions (Figure 3A). In contrast,
mutation of phenylalanine 456 to alanine resulted in a Figure 3C). Expression of GFP-WIP-WBDF454A resulted
in a significant reduction in the level of inhibition tocomplete lack of recruitment, as did subsitution of both
phenylalanine residues (Figure 3A). While recruitment 33.6%  16.2%. This was reduced still further to
17.8%  5.2% in the case of GFP-WIP-WBDF456A andprovides a qualitative assay, it gives no quantitative
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Figure 3. Analysis of the Effect of Mutation of Phenylalanine 454 and 456 in the WASP Binding Domain of WIP In Vivo
(A) Immunofluorescence images showing the localization of GFP-tagged mutant constructs of WIP-WBD (green), as indicated above the
panels, to Shigella (blue) nucleating actin tails (red) in infected cells. GFP-WBDF454A, in contrast to GFP-WBD, is largely not recruited to
Shigella (open arrowhead). In rare cases, however, as shown here GFP-WBDF454A is localized to the bacterium (filled arrowhead). In contrast,
GFP-WBDF456A and GFP-WBDF454/456A are never recruited to the bacterium (open arrowheads). The scale bar represents 5 m.
(B) Immunofluorescence images showing that, in contrast to GFP-WBD, expression of GFP-WBDF454/456A does not block the recruitment
of endogenous N-WASP to vaccinia and actin tail formation. The scale bar represents 20 m.
(C) Quantification of vaccinia-induced actin tail efficiency in cells overexpressing the indicated GFP construct. The data represent the average
from four independent experiments, and error bars represent standard deviations.
Brief Communication
1621
Figure 4. Interaction with N-WASP Is Required for Recruitment of WIP to Vaccinia and Shigella
Immunofluorescence images of cells infected with vaccinia or Shigella expressing the GFP-WIP mutants F454A, F456A, and F454/456A. GFP-
WIP, and to a lesser degree GFP-WIP-F454A, are recruited to vaccinia or Shigella nucleating actin tails (filled arrowheads). In contrast, GFP-
WIP-F456A and GFP-WIP-F454/456A are not recruited to the pathogen surface (open arrowheads) but are observed down the actin tail. The
scale bar represents 2 m.
to 13.5%  7.6% when both mutations were combined possibility that additional WH1-independent interac-
tions might also contribute to WIP recruitment and stabi-(Figure 3C). Consistent with its lack of inhibition of actin
tails, GFP-WIP-WBDF454/456A did not block recruit- lization of the complex on the virus. To explore this
possibility, we examined the localization of full-lengthment of N-WASP to vaccinia (Figure 3B). Taken together,
our in vivo data using the Shigella and vaccinia pathogen WIP containing the phenylalanine 454 and 456 alanine
substitutions in Shigella and vaccinia-infected cells. Wesystems confirm that we have identified the N-WASP
WH1 binding motif in WIP. found that GFP-WIP-F454A was still recruited to Shigella
and vaccinia nucleating actin tails, albeit at reducedObservations by Snapper et al. have demonstrated
that, in the absence of N-WASP, vaccinia is unable to levels when compared to GFP-WIP, and this finding is
consistent with weaker binding to the N-WASP WH1recruit WIP [18], which is consistent with the suggestion
that both proteins are recruited as a complex [1]. While domain in vitro (Figure 4). GFP-WIP-F456A or double
phenylalanine mutants were never recruited to eitherthis study formally shows that N-WASP is essential for
actin-based motility of vaccinia, it does not rule out the Shigella or vaccinia (Figure 4). It was noticeable that all
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the Enabled/VASP homology 1 domain-peptide complex: a keyGFP-WIP mutants had a more pronounced association
component in the spatial control of actin assembly. Cell 97,along the length of the actin tail than wild-type WIP.
471–480.This was especially apparent in the case of Shigella-
9. Niebuhr, K., Ebel, F., Frank, R., Reinhard, M., Domann, E., Carl,
induced actin tails (Figure 4). This localization is consis- U.D., Walter, U., Gertler, F.B., Wehland, J., and Chakraborty, T.
tent with the observation that the protein is associated (1997). A novel proline-rich motif present in ActA of Listeria
monocytogenes and cytoskeletal proteins is the ligand for thewith actin stress fibers in vivo and can bind actin fila-
EVH1 domain, a protein module present in the Ena/VASP family.ments in vitro [2, 19]. Taken together, our observations
EMBO J. 16, 5433–5444.using WIP mutants indicate that, while they still bind
10. Ball, L.J., Kuhne, R., Hoffmann, B., Hafner, A., Schmieder, P.,Nck (data not shown), their ability to interact with the
Volkmer-Engert, R., Hof, M., Wahl, M., Schneider-Mergener, J.,
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ing affinity. EMBO J. 19, 4903–4914.WIP mutants deficient in WH1 binding with the actin
11. Renfranz, P.J., and Beckerle, M.C. (2002). Doing (F/L)PPPPs:cytoskeleton in vivo suggests that additional N-WASP-
EVH1 domains and their proline-rich partners in cell polarity andindependent roles must also exist for WIP, as previously
migration. Curr. Opin. Cell Biol. 14, 88–103.suggested by Vetterkind et al. [19]. Future studies must
12. Callebaut, I., Cossart, P., and Dehoux, P. (1998). EVH1/WH1
address what these roles are and whether WIP as well domains of VASP and WASP proteins belong to a large family
as the related CR16 and WICH act as adapters or play including Ran-binding domains of the RanBP1 family. FEBS
Lett. 441, 181–185.a more active regulatory function when they are com-
13. Ho, H.Y., Rohatgi, R., Ma, L., and Kirschner, M.W. (2001). CR16plexed to N-WASP or WASP.
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